HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pharmacological nephroprotection in chronic kidney disease: current opportunities and perspectives (review of foreign literature)].

Abstract
A brief literature review analyses pharmacoprotective strategy in most widespread forms of chronic kidney disease: metabolic syndrome, hypertensive angionephrosclerosis. diabetic and non-diabetic nephropathy Nephroprotective properties of the blockers of rennin-angiotensin-aldosteron system and other antiadrenergic drugs, diuretics, hypolipidemic, antianemic and hypouricemic drugs, active metabolites of vitamin D, metphormine and glytasones are reviewed. The highest efficacy of combined pharmaconephroprotection is demonstrated.
AuthorsA Iu Nikolaev
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 84 Issue 6 Pg. 77-80 ( 2012) ISSN: 0040-3660 [Print] Russia (Federation)
PMID22997925 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Drug Therapy, Combination (methods, trends)
  • Humans
  • Kidney (drug effects)
  • Renal Insufficiency, Chronic (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: